Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 32

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 32
---
”) expenses, excluding depreciation, amortization of intangible assets and impairments.  Included within these categories of expenses are overhead expenses, stock compensation expense, restructuring charges and allocated corporate expenses. 

72

The following table presents additional detailed segment data for the years ended December 31 ($ in millions):202420232022Identifiable assets:Biotechnology$34,605 $37,421 $37,536 Life Sciences23,211 23,730 17,572 Diagnostics14,204 14,552 14,722 Other5,522 8,785 9,739 Discontinued operations— — 4,781 Total$77,542 $84,488 $84,350 Capital expenditures, gross:Biotechnology$447 $417 $405 Life Sciences391 320 325 Diagnostics550 546 382 Other4 100 6 Total$1,392 $1,383 $1,118 Operations in Geographical Areas:Year Ended December 31($ in millions)202420232022Sales:United States$9,927 $9,579 $11,289 China2,805 3,143 3,611 All other (each country individually less than 5% of total sales)11,143 11,168 11,743 Total$23,875 $23,890 $26,643 Property, plant and equipment, net:United States$2,585 $2,304 $1,839 United Kingdom519 371 239 Sweden384 425 429 Germany251 238 204 All other (each country individually less than 5% of total property, plant and equipment, net)1,251 1,215 998 Total$4,990 $4,553 $3,709 

NOTE 7.  INCOME TAXES 

Earnings from continuing operations before income taxes for the years ended December 31 were as follows ($ in millions):202420232022United States$1,002 $1,310 $2,527 Non-U.S.3,644 3,734 4,619 Total$4,646 $5,044 $7,146 

73

The provision for income taxes from continuing operations for the years ended December 31 were as follows ($ in millions):202420232022Current